Evangelia A. Papakonstanti
Irakleion, ESYE43, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
IOA-244, a novel p110δ PI3K inhibitor, blocks breast tumour progression on either mono- or combined-therapy.
Journal: Cell death discovery
Published: October 28, 2025
A combined opposite targeting of p110δ PI3K and RhoA abrogates skin cancer.
Journal: Communications biology
Published: March 07, 2023
p110δ PI3K as a therapeutic target of solid tumours.
Journal: Clinical science (London, England : 1979)
Published: December 22, 2019
Pharmacological inactivation of the PI3K p110δ prevents breast tumour progression by targeting cancer cells and macrophages.
Journal: Cell death & disease
Published: December 14, 2017
Galectin-1 overexpression in endometriosis and its regulation by neuropeptides (CRH, UCN) indicating its important role in reproduction and inflammation.
Journal: PloS one
Published: August 14, 2014
p110δ PI3 kinase pathway: emerging roles in cancer.
Journal: Frontiers in oncology
Published: December 04, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026